Saturday, January 3, 2015

Poor Avastin responders in AMD & DME may have increased risk to obstructive sleep apnea

Obstructive sleep apnea
from Wikipedia




Poor responders to Bevacizumab (Avastin) in patients with age-related macular degeneration (AMD) and diabetic macular edema (DME) may have increased risk to obstructive sleep apnea (OSA). To read more, click here.

No comments:

Post a Comment